The experimental results showed that compared with the normal group, the contents of e-NOS and VEGF in the brain tissue of the diabetes group were significantly reduced, and the levels of e-NOS, VEGF mRNA, and protein expression in the 1,25-D3 treatment group were significantly higher than those in the diabetes group. This evidence concerns the gene VEGFA and diabetes mellitus.